Algomedix Competitors and Similar CompaniesClear all
Algomedix's competitors and similar companies include CTI BioPharma, NeurOp and Crinetics Pharmaceuticals.
 Algomedix Algomedix is a company engaged in the development of Transient Receptor Potential (TRP) therapeutics to treat serious medical needs, including chronic and acute pain. |  CTI BioPharma CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers. |  NeurOp NeurOp is a biotechnology company developing medicines for the treatment of central nervous system (CNS) disorders including stroke, severe pain, subarachnoid hemorrhage (SAH), and treatment-resistant depression. |  Crinetics Pharmaceuticals Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors. | |
Founding Date | Founding Date 2010 | Founding Date 1992 | Founding Date 2002 | Founding Date 2008 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Mill Creek, US HQ | Locations Seattle, US HQ Köln, DE | Locations Atlanta, US HQ | Locations San Diego, US HQ |
Employees | Employees 1 | Employees 2546% decrease | Employees 6 | Employees 43751% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.2 b | Valuation ($) N/A | Valuation ($) 5.1 b |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $53.9m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $7.7m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $3.5m (FY, 2022) | Cost of goods N/A | Cost of goods $1.1m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $50.4m (FY, 2022) | Gross profit N/A | Gross profit $6.6m (FY, 2025) |
Net income | Net income N/A | Net income ($93m) (FY, 2022) | Net income N/A | Net income ($465.3m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 105m | Total funding raised N/A | Total funding raised $ 41.5m |
For sources of this data, please see the company profile
View Company Profiles
CTI BioPharma
HQ
Seattle, US
Employees
25↓ 46% decrease
CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers.
View companyNeurOp
HQ
Atlanta, US
Employees
6
NeurOp is a biotechnology company developing medicines for the treatment of central nervous system (CNS) disorders including stroke, severe pain, subarachnoid hemorrhage (SAH), and treatment-resistant depression.
View companyCrinetics Pharmaceuticals
HQ
San Diego, US
Employees
437
Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors.
View company